ICMR: Hydroxychloroquine could have side-effects

NEW DELHI: Healthcare workers who took anti-malaria drug hydroxychloroquine (HCQ) suffered from its side-effects like abdominal pain, nausea and hypoglycemia according to a study conducted by the Indian Council of Medical Research (ICMR).

ICMR head of epidemiology and communicable diseases, Dr R R Gangakhedkar said that “A study has been launched to know the side-effects of HCQ. We found that healthcare workers having an average age of 35 years took these drugs and 10% reported abdominal pain, 6% reported nausea and 1.3% reported hypoglycemia.”
“Around 22% of these healthcare workers also had other conditions like diabetes, cardiovascular diseases and blood pressure and therefore, probably out of fear, took HCQ as a preventive measure”, he further added.
“We are not doing a trial and we don’t have sufficient evidence base to do a trial. There will be about 480 patients who will be enrolled and it will go on for about 2.5 months,” Dr Gangakhedkar said.

ICMR is also researching to find out the other effects of HCQs.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port